Publication:
Metabolic Syndrome In Thyroid Disease

dc.contributor.authornull Iskender Ekinci
dc.date.accessioned2026-11-13T07:54:40Z
dc.date.issued2025-01-09
dc.description.abstractThyroid diseases significantly influence metabolic parameters, including blood pressure regulation, glucose metabolism, obesity, hyperlipidemia, and nonalcoholic fatty liver disease (NAFLD). Hypothyroidism is often linked to hypertension, insulin resistance, and dyslipidemia, while hyperthyroidism may induce weight loss, insulin resistance, and dyslipidemia. Both hypo- and hyperthyroidism impact blood pressure regulation, glucose homeostasis, and adiposity. Dyslipidemia is frequently observed in thyroid disorders, with hypothyroidism associated with elevated cholesterol levels and hyperthyroidism with altered lipid profiles. Additionally, thyroid dysfunction contributes to the development of NAFLD. There is a close relationship between thyroid hormones and metabolic syndrome components, as well as the development of metabolic syndrome.en
dc.identifier.doi10.2174/9789815322132125010026
dc.identifier.scopus2-s2.0-85216066599
dc.identifier.urihttps://doi.org/10.2174/9789815322132125010026
dc.identifier.urihttps://hdl.handle.net/20.500.12645/42894
dc.language.isoen
dc.publisherBENTHAM SCIENCE PUBLISHERS
dc.rightsclosedAccess
dc.sourceOpenAire
dc.titleMetabolic Syndrome In Thyroid Diseaseen
dc.typePart of book or chapter of book
dspace.entity.typePublication
local.indexed.atScopus

Files